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Abstract
Background: Cardiac insults such as ischemia, infarction, hypertrophy and dilatation are often
accompanied by altered abundance and/or localization of the connexin43 gap junction protein,
which may predispose towards arrhythmic complications. Models of chronic dyssynchronous
cardiac activation have also been shown to result in redistribution of connexin43 in
cardiomyocytes. We hypothesized that alterations in connexin43 expression and localization in the
mouse heart might be induced by ventricular pacing over a short period of time.
Results: The subdiaphragmatic approach was used to pace a series of wild type mice for six hours
before the hearts were removed for analysis. Mice were paced at 10–15% above their average
anesthetized sinus rate and monitored to ensure 1:1 capture. Short-term pacing resulted in a
significant reduction in connexin43 mRNA abundance, a partial redistribution of connexin43 from
the sarcolemma to a non-sarcolemmal fraction, and accumulation of ubiquitinated connexin43
without a significant change in overall connexin43 protein levels. These early pacing-induced
changes in connexin43 expression were not accompanied by decreased cardiac function, prolonged
refractoriness or increased inducibility into sustained arrhythmias.
Conclusion: Our data suggest that short-term pacing is associated with incipient changes in the
expression of the connexin43 gap junction, possibly including decreased production and a slowed
rate of degradation. This murine model may facilitate the study of early molecular changes induced
by pacing and may ultimately assist in the development of strategies to prevent gap junction
remodeling and the associated arrhythmic complications of cardiac disease.
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Sudden cardiac death is a common and tragic complica-
tion of heart disease that affects more than 400,000 Amer-
icans annually [1]. The pathophysiology of myocardial
remodeling, at functional and molecular levels, results in
a substrate ripe for arrhythmic complications [2]. Remod-
eling of connexin43 (Cx43) gap junction distribution and
expression has been described in ischemia, infarction,
hibernating myocardium and dilated cardiomyopathy [3-
6] and is a potentially significant contributor to the
arrhythmogenicity of cardiac disease [7-9]. Indeed, we
have observed that decreased expression and mislocaliza-
tion of Cx43 to the lateral borders of myocytes in the peri-
infarct zone (a process termed "structural gap junction
remodeling") was found to correspond spatially to the
central common pathway of figure-of-eight reentrant ven-
tricular tachycardia circuits [6].
Chronically altered ventricular activation, such as that
induced in canine models using pacing or radiofrequency
ablation of the left bundle branch, has been associated
with focal structural gap junction remodeling [10,11].
Areas of gap junction remodeling observed in the dog
heart after 21 days of pacing were localized exclusively to
regions in close proximity to the pacing electrode [11].
Since less than an hour of ischemia-reperfusion in an iso-
lated rat heart is required to demonstrate intracellular
redistribution of Cx43 [12], we predicted that pacing-
induced gap junction remodeling might occur over a short
term.
To test our hypothesis, we adapted the subdiaphragmatic
approach for programmed electrical stimulation in the
mouse heart [13] to allow for six hours of single lead ven-
tricular pacing at rates just above those of sinus rhythm.
We used a murine model since it might facilitate molecu-
lar studies of remodeling by eventually allowing for the
use of transgenic models to elucidate mechanisms. Pacing
via the subdiaphragmatic approach was associated with
significant mechanical dyssynchrony. After six hours of
pacing, we observed a significant decrease in Cx43 mRNA
levels, evidence of intracellular redistribution of Cx43
protein, and an accumulation of ubiquitinated Cx43 in
the paced hearts. Our findings were consistent with
decreased production and disrupted degradation of Cx43,
possibly accounting for preserved total Cx43 protein lev-
els despite decreased mRNA expression and reduced
membrane immuno-localization of Cx43 after pacing.
These data suggest that alterations in the expression and
distribution of Cx43 occur after limited exposure to pac-
ing. Changes in Cx43 expression patterns may contribute
to increased arrhythmogenicity in the presence of addi-
tional insults to the heart. Since gap junction alterations
may be preventable or reversible, elucidating the path-
ways involved may ultimately allow for the pharmaco-
logic targeting of intermediaries in those pathways and
the prevention of arrhythmic complications.
Methods
Pacing Procedure
Mice aged 3 – 4 months were used for these experiments.
All studies were performed in accordance with the regula-
tions of the Institutional Animal Care and Use Committee
of the New York University School of Medicine (New
York, NY). The C57BL/6J strain was used for all experi-
ments except for immunoblotting of ventricular lysates
and quantification of mRNA expression, for which CD-1
mice were used. Mice were anesthetized with inhaled iso-
flurane (4 vol% induction, 1.5 vol% maintenance; Baxter,
Deerfield, IL) and immobilized on a heating pad set to
37°C. Electrocardiographic signals from limb leads were
monitored during the experiment and recordings were
obtained prior to the initiation of pacing, during pacing
(to document 1:1 capture) and following cessation of pac-
ing.
Following recording of the baseline electrocardiogram, a
1 cm midline incision was made in the epigastric region.
A custom-designed UE-GM1 cardiac stimulating electrode
with a 200 μm monopolar platinum tip (Frederick Haer &
Co., Bowdoinham, ME) mounted on a micromanipulator
(Fine Science Tools, Inc., North Vancouver, BC, Canada)
was inserted through the diaphragm directly into contact
with the surface of the beating right ventricle. Electrode
contact was ensured by monitoring the electrocardio-
graphic activity. Pacing was performed with a Model 2352
Programmable Stimulator (Medtronic, Minneapolis,
MN). Output was set at twice the stimulating threshold in
all animals, with a pulse width of 1.0 ms. Pacing cycle
lengths were set and maintained at 10–15% above the
underlying heart rate, to ensure 100% capture for 6 hours.
To serve as controls, age-, sex- and strain-matched mice
were prepared and anesthetized with the pacing electrode
placed into contact with the heart identically to the paced
cohort, but the programmable stimulator was not
switched on ("sham-paced").
Electrocardiographic Recordings
Electrocardiographic signals were recorded as previously
described. Electrocardiographic intervals were calculated
from leads I, II and III recorded at the beginning of each
study and after the completion of the pacing protocol.
Echocardiography
Echocardiography was performed according to a previ-
ously described protocol [14] on paced and sham-paced
mice (n = 6 in each group), prior to and during or imme-
diately following six hour pacing and sham protocols.Page 2 of 12
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raphy machine equipped with a 15 MHz linear probe.
In Vivo Electrophysiology
Programmed electrical stimulation (PES) was carried out
in paced and sham-paced mice at baseline and after the
pacing protocol as described previously [13]. The PES pro-
tocol consisted of trains of eight beats at pacing cycle
lengths of 100 ms and 80 ms, followed by single extras-
timuli for the determination of ventricular effective refrac-
tory period (VERP) and double extrastimuli to assess for
inducible arrhythmias. PES data represent the average of
two trials at separate sites on each heart.
Tissue Handling and Immunolabeling
Following the pacing procedure, hearts destined for
immunostaining were rapidly excised and frozen in Tissue
Tek OCT compound (Sakura Finetek USA, Inc., Torrance,
CA). Five micron-thick sections were cut in an HM 560
cryostat (Microm, Walldorf, Germany) at -20°C, placed
onto Superfrost/Plus microscope slides (Fisher Scientific,
Pittsburgh, PA) and fixed in acetone. We selected frozen
sections to evaluate the left ventricle from basal, mid-ven-
tricular, and apical regions. We defined the basal region as
those sections proximal to the papillary muscles; mid-
ventricular regions were those sections of LV with clearly
identified papillary muscles; and apical regions were dis-
tal to the papillary muscles. We also evaluated apical and
basal sections of the right ventricle.
Sections were blocked and then double-stained with a
custom-made rabbit polyclonal anti-Cx43 antibody [15]
at 1:1000 and wheat germ agglutinin to visualize myocyte
borders as previously described [16]. For visualization of
cadherin staining, frozen sections were incubated with a
rabbit anti-pan-cadherin antibody (1:5000; Sigma), fol-
lowed by a Texas Red-conjugated goat anti-rabbit second-
ary antibody (Jackson ImmunoResearch Laboratories)
and a FITC-conjugated anti-Cx43 antibody. Stained sec-
tions were visualized on an Axioskop 2 Plus fluorescence
microscope. Images were collected using uniform expo-
sure settings for each staining run on an Axiocam camera
with AxioVision 4.30 software (Carl Zeiss, Munchen-Hall-
bergmoos, Germany).
Quantification of Cx43 and Cadherin Immunosignal
Images of immuno-stained sections from paced and
sham-paced hearts were obtained from blinded slides and
digitally archived for offline analysis. Blinded image files
were uniformly thresholded by eliminating signal-free
areas above and below the distribution of intensity values
using the histogram function on Adobe Photoshop. Dig-
ital image processing was then performed according to
previously established techniques [17], again in a blinded
fashion, with NIH Image J to determine Cx43 and cad-
herin signal area as a percentage of total tissue area, as well
as Cx43 plaque size and the number of Cx43 plaques per
40× field.
Immunoblotting and Densitometry
For the evaluation of total protein levels by immunoblot-
ting, endocardial ventricular tissue from paced and sham-
paced hearts was prepared by Dounce homogenization in
lysis buffer supplemented with Complete protease inhib-
itor cocktail (Roche, Mannheim, Germany). Endocardial
samples were prepared by mounting the excised LV free
wall in an OCT block, separating the endocardial, mid-
myocardial and epicardial regions by sectioning on an
HM 560 cryostat and homogenizing as above. The inner
third of the LV free wall was considered the endocardial
region, middle third mid-myocardial and outer third epi-
cardial. Protein concentrations were determined by Brad-
ford assay performed in triplicate and equal loading was
confirmed with coomassie staining. Proteins were electro-
phoresed on 10% SDS-PAGE gels and transferred onto
nitrocellulose blots (Bio-Rad Laboratories, Hercules, CA).
Immunoblots were blocked followed by incubation with
appropriate primary antibodies directed against Cx43,
cadherin (see above), Cx45 [18], Cx40 (Alpha Diagnos-
tics, San Antonio, TX) and GAPDH (Chemicon/Millipore,
Billerica, MA). HRP-conjugated secondary antibody
(Santa Cruz Biotechnology, Santa Cruz, CA) was then
applied, followed by HyGlo chemiluminescent process-
ing (Denville Scientific, Metuchen, NJ) and autoradiogra-
phy. At least two separate experiments were quantified by
scanning the autoradiograms on a Bio-Rad Gel Doc GS
800 and calculating band intensity using Quantity One
software (Bio Rad, Hercules, CA). Connexin band intensi-
ties were normalized to the relative intensity of the corre-
sponding GAPDH band for each sample. Results were
expressed as a percentage of matched sham-paced con-
trols.
Fraction Preparation and Immunoprecipitation
To determine sarcolemmal and non-sarcolemmal Cx43
concentrations, fractionation of samples was performed
as described [15,19]. Briefly, heart samples were Dounce
homogenized, centrifuged at 500 × g for 10 minutes to
remove insolubles and layered over a 45% sucrose cush-
ion. After centrifuging at 7000 × g for 20 minutes, the
supernatant (non-sarcolemmal fraction) was separated
from the cloudy layer immediately overlying the sucrose
(sarcolemmal fraction). Protein concentrations in each
fraction were determined by Bradford assay performed in
triplicate and equal loading was confirmed with coomas-
sie staining. The resulting fractions were analyzed by SDS-
PAGE and Western blotting.
For immunoprecipitation, 50 μg of total heart lysate was
incubated with polyclonal anti-Cx43 antibody. After addi-Page 3 of 12
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(Roche) to the samples, the protein A suspension was cen-
trifuged at 5000 × g and the supernatant was removed.
The protein A beads were washed in IP buffer and resus-
pended in loading buffer prior to incubation at 100°C
and analysis by SDS-PAGE. The resulting blots were incu-
bated with a monoclonal antibody directed against ubiq-
uitin (FK2, Biomol) and processed as above.
RNA Isolation and Quantitative Real-Time PCR (qRT-
PCR)
To isolate total RNA, the LV free walls of paced and sham-
paced hearts were excised, mounted in OCT and snap fro-
zen in liquid nitrogen. Endocardial and epicardial thirds
were collected by sectioning through the LV free wall as
described above. RNA was isolated using Trizol (Invitro-
gen, Carlsbad, CA) according to the manufacturer's rec-
ommendations. RNA quality was verified with the Agilent
2100 Bioanalyzer (Agilent Technologies, Santa Clara,
CA). The concentration of RNA was determined by the
Quant-iT RiboGreen RNA Assay Kit (Invitrogen, Carlsbad,
CA). Real time quantitative PCR was performed using the
ABI Prism 7700 Sequence Detection System (Applied Bio-
systems, Foster City, CA). Cx43 primer sequences, located
in the 3' untranslated region, were as follows: forward
primer sequence was 5'-GTGCCGGCTTCACTTTCAT-
TAAG-3'; reverse primer sequence was 5'-ACTGAC-
CTCGCGGAACC-3'; probe sequence was 5'-
TTTCTCTCCACGGGTCT-3'. All data were normalized to
Cyclophilin A (primer sequences as per [20]) and
expressed as fold change compared to the sham-paced
controls. Negative controls were performed for each of the
samples, in which reverse transcriptase was not added
prior to RNA quantification. Results per animal represent
the mean of six measurements of each endocardial and
epicardial sample.
Statistics
Data are expressed as mean ± SEM. Quantitative immun-
ofluorescence data were compared between groups with
ANOVA using StatView (SAS Institute, Inc., Cary, NC).
Data from electrocardiography, echocardiography, PES,
immunoblot densitometry and qRT-PCR were compared
between groups with unpaired two-tailed t-tests (Micro-
soft Excel). Electrocardiographic indices, echocardio-
graphic measurements and ERP values obtained during or
after the pacing protocol were compared to baseline meas-
urements with paired two-tailed t-tests (Microsoft Excel).
P < 0.05 was considered statistically significant.
Results
Stimulating Electrode is Consistently Positioned on the 
Right Ventricle
For ease of pacing and reliability, we used the subdia-
phragmatic approach, which allows for placement of the
stimulating electrode on the heart without necessitating
sternotomy, thoracotomy, mechanical ventilation or
manipulation of the vasculature [13]. For the investiga-
tion of probe placement after the pacing protocol was
completed, a midline sternotomy was performed at the
end of four consecutive experiments. In all four animals
examined in this fashion, the stimulating electrode tra-
versed the diaphragm and made contact with the right
ventricular (RV) surface without puncturing the heart
(Figure 1A). Local structures (including the abdominal
viscera, diaphragm and lungs) were not disrupted by the
electrode. Thus, the pacing model employed in this study
can be considered as single-lead RV epicardial pacing.
Threshold is Unchanged after Pacing Protocol
Since our objective was to model altered activation rather
than induce tissue damage [21], we limited the stimulator
Pacing from the Subdiaphragmatic Approach is Associated with Mechanical DyssynchronyFigure 1
Pacing from the Subdiaphragmatic Approach is 
Associated with Mechanical Dyssynchrony. A) For 
illustrative purposes only, a mid-line sternotomy was per-
formed after the pacing experiment to demonstrate that the 
tip of the stimulating electrode is positioned at the epicardial 
surface of the right ventricle. B) M-mode echocardiography 
reveals dyssynchrony of ventricular contraction during subdi-
aphragmatic pacing with a substantially greater delay in the 
time between septal (yellow arrow) and posterior wall thick-
ening (red arrow) compared to non-paced baseline. C) Sep-
tal-to-Posterior Wall Motion Delay (SPWMD), a 
measurement of the time interval between septal and poste-
rior wall systolic thickening as demonstrated in Panel A, is 
significantly prolonged during pacing in comparison to the 
SPWMD measured prior to initiation of pacing. D) A surface 
electrocardiogram recorded during pacing demonstrates a 
wide and aberrantly conducted paced complex in compari-
son to a sinus beat recorded before pacing.
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(mean stimulator output was 0.366 ± 0.011 mA). The
average threshold prior to pacing was 0.165 ± 0.007 mA
(n = 65). In a subset of eight mice, the threshold was
determined after pacing. In this group the average post-
pacing threshold was 0.162 ± 0.026 mA (p = NS compared
to pre-pacing values). The unchanged threshold values
after pacing underscore the stability of the experimental
preparation.
Short-Term Pacing Is Associated with Mechanical 
Dyssynchrony
To determine whether short-term pacing influenced syn-
chrony of cardiac contraction, we examined mice prior to
and during pacing using echocardiography. The septal-to-
posterior wall motion delay (SPWMD), an echocardio-
graphic index of dyssynchronous contraction [22,23],
increased significantly from 7.8 ± 2.5 ms before pacing to
27.9 ± 2.4 ms during pacing (p < 0.01; n = 6 each; Figure
1B and 1C). Delay in onset of systolic wall thickening
measured from the septal to the posterior walls also
increased significantly during pacing (12.8 ± 1.1 ms at
baseline vs. 31.6 ± 1.4 ms during pacing, p < 0.001). As
expected, surface electrocardiograms demonstrated sub-
stantial widening of the QRS complex during pacing, sug-
gesting aberrant intraventricular electrical conduction
(Figure 1D). Fractional shortening was marginally
decreased from 44.2 ± 2.0% at baseline to 37.2 ± 2.8%
during pacing (p < 0.05; Table 1).
Although global ventricular function was slightly dimin-
ished during pacing, fractional shortening was not signif-
icantly altered after cessation of pacing in the paced mice
compared to matched sham-paced controls or compared
to their baseline values. Similarly, left ventricular dimen-
sions and wall thicknesses were not significantly changed
in paced mice compared to matched sham-paced controls
or baseline values (Table 2). Thus, short-term pacing was
associated with dyssynchrony during pacing and a slight
decrement in ventricular function that normalized imme-
diately after cessation of pacing.
Short-Term Pacing Results in Focal Reduction of Cx43 
Immunosignal Area at the Endocardium of the Left 
Ventricular Free Wall
To characterize the effect of short-term pacing-induced
dyssynchrony on gap junction distribution in the mouse
heart, we paced mice for 6 hours (3–4 half-lives of Cx43)
[24-26] and assessed Cx43 localization using immunoflu-
orescence staining. In sham-paced mice, Cx43 immu-
nosignal was arrayed in heterogeneously distributed
membrane-associated plaques throughout the myocar-
dium (Figure 2A and 2B). In the sham-paced hearts, Cx43
signal area as a percentage of total tissue area was greater
in the endocardial region of the left ventricular (LV) free
wall (9.12 ± 1.20%) than in the epicardial region (6.82 ±
0.40%; p < 0.05; Figure 2M). After 6 hours of pacing, how-
ever, Cx43 immunosignal area was reduced specifically at
the endocardial region of the LV free wall (6.76 ± 0.60%)
in comparison to the endocardium of sham-paced con-
trols (p < 0.05), without a detectable change in epicardial
Cx43 signal (6.41 ± 0.30%; Figure 2C and 2D and Figure
2M; data are from n = 6 sham and 6 paced hearts).
Post-hoc analysis showed that the Cx43 signal area was
decreased significantly only at the basal LV endocardial
segments in paced hearts compared to sham-paced hearts
(6.38 ± 0.50% in paced vs. 9.36 ± 1.28% in sham, p <
0.01). There were trends at the apical (6.76 ± 0.89% in
paced vs. 7.97 ± 0.96% in sham) and mid-ventricular
(7.15 ± 0.69% in paced vs. 9.10 ± 1.59% in sham) LV
endocardial segments toward decreased Cx43 signal area
in paced hearts, although these were not statistically sig-
nificant.
There was no difference in Cx43 signal area between sham
(3.40 ± 0.25%) and paced (3.91 ± 0.45%) RV sections.
Specifically at the RV apex where the stimulating electrode
was placed, there was no statistically significant difference
in Cx43 signal area between sham (3.51 ± 0.46%) and
paced hearts (4.16 ± 0.53%; Figure 2P and 2Q).
Trends in endocardial gap junction plaque sizes mirrored
changes in Cx43 immunosignal area, although differences
in plaque size among groups were not statistically signifi-
cant (Figure 2N). There was no significant difference in
the number of gap junction plaques per 40× field in sham
and paced endocardial and epicardial regions (Figure
2O). Thus, the epicardial-to-endocardial gradient of
increasing Cx43 signal area observed in the LV free wall of
sham-paced hearts, which has been described previously
by other investigators[17], was eliminated after 6 hours of
pacing due to a focal decrease in Cx43 immunosignal area
at the endocardium of the LV free wall.
Table 1: Echocardiographic Measurements before Initiation of 
Pacing and During Pacing in Wildtype C57BL/6J Mice
Pre-Pacing (n = 6) During Pacing (n = 6)
IDD, mm 3.8 ± 0.14 3.6 ± 0.08
IDS, mm 2.1 ± 0.10 2.2 ± 0.12
Fractional Shortening, % 44.2 ± 2.0 37.2 ± 2.8*
AWTs, mm 1.1 ± 0.14 0.85 ± 0.08
AWTd, mm 0.53 ± 0.09 0.47 ± 0.05
PWTs, mm 1.4 ± 0.14 1.2 ± 0.10
PWTd, mm 1.0 ± 0.11 0.85 ± 0.13
Data is presented as group means ± SEM. Comparisons between 
groups were performed with unpaired T-tests. *, p < 0.05. IDD, IDS, 
intraventricular dimensions at end-diastole, end-systole; AWTs, 
AWTd, anterior wall thicknesses at end-systole, end-diastole; PWTs, 
PWTd, posterior wall thicknesses at end-systole, end-diastole.Page 5 of 12
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Unaffected by Short-Term Pacing
Adherens junctions, like gap junctions, are concentrated
at the intercalated discs of adult cardiac myocytes. Since
the expression pattern of Cx43 immunosignal was altered
by short-term pacing, we investigated whether immu-
nosignal area of cadherin, a critical component of the
adherens junction with a half life of 5–6 hours [27,28],
was also changed. Unlike the epicardial-to-endocardial
gradient of increasing Cx43 immunosignal area, there was
no difference in cadherin immunosignal area between
epicardial and endocardial regions in sham-paced control
hearts (Figure 2E and 2F). Furthermore, cadherin signal
area in both epicardial and endocardial regions remained
unchanged after 6 hours of pacing (p = NS; n = 6 sham
and 6 paced hearts; Figure 2G and 2H). This suggests that
the reduction in endocardial Cx43 signal area with pacing
occurs in the absence of changes in the distribution of the
adherens junctions.
To determine whether short-term pacing was associated
with redistribution of Cx43 signal away from the interca-
lated disc, we performed colocalization analysis of Cx43
and cadherin immunosignal (Figure 2I–L). The percent-
age of Cx43 immunosignal colocalizing with cadherin in
the paced hearts was unchanged in comparison to sham-
paced controls. This suggests that short-term pacing in the
mouse heart does not affect the process whereby Cx43
protein is directed to sites of adherens junction aggrega-
tion in the sarcolemma [29].
To further assess the effect of short-term pacing on target-
ing of Cx43 protein along the sarcolemma, we used a sub-
jective scoring system in which the degree of Cx43
immunosignal at the lateral myocyte borders in sections
from paced and sham-paced hearts was compared. Paced
and sham heart sections were blindly assigned scores
ranging from 0 (no lateralization) to 3 (extensive laterali-
zation). We found that sham sections demonstrated
extensive subjective lateralization of Cx43 signal (2.75 ±
0.25) and that the extent of lateralization did not appear
significantly different in the paced hearts (2.40 ± 0.40, p =
NS; n = 4 sham and 5 paced).
Expression of Cx43 mRNA is Down-Regulated in the LV 
Free Wall after 6 hours of Pacing
Since Cx43 immunosignal area was reduced at the LV
endocardium after 6 hours of pacing, we investigated the
effects of short-term pacing on Cx43 mRNA levels in the
LV free wall endocardial and epicardial regions of paced
and sham-paced control hearts. As shown in Figure 3,
qRT-PCR demonstrated a 2.5 ± 0.1-fold down-regulation
in expression of Cx43 mRNA at the endocardial region of
the paced hearts compared to the sham-paced group (p <
0.001; n = 3 sham and 3 paced). Furthermore, a 2.0 ± 0.1-
fold reduction in Cx43 mRNA expression was observed at
the epicardial regions of the paced hearts compared to
sham-paced controls (p = 0.001; n = 3 sham and 3 paced).
Thus, six hours of pacing at rates just above those of sinus
rhythm resulted in significant reductions in Cx43 mRNA
levels at the LV free wall.
Cx43 Abundance is Preserved in the LV Endocardial Region 
after Short-Term Pacing
Since short-term pacing in the murine heart resulted in
down-regulation of Cx43 mRNA levels in the LV and
decreased immunosignal of Cx43 at the endocardium, we
investigated whether endocardial Cx43 protein abun-
dance was affected by pacing. Surprisingly, there was no
significant change in Cx43 protein expression in the paced
LV endocardial region compared to sham-paced controls
(n = 11 sham and 11 paced; Figure 4A). Densitometry val-
ues of the slower migrating (upper) Cx43 bands expressed
as a ratio to the lower-most band was unchanged in paced
compared to sham-paced samples, suggesting that the
overall phosphorylation status of Cx43 was unaffected by
short-term pacing. Expression levels of cadherin, Cx40
and Cx45 by immunoblotting were also statistically
unchanged after pacing in the LV free wall endocardial
myocardium (n = 7 sham and 7 paced; Figure 4B). Thus,
Table 2: Echocardiographic Measurements in C57BL/6J Wildtype Mice after Cessation of Short-Term Pacing
Sham-Paced, 6 hr (n = 6) Paced, 6 hr (n = 6)
IDD, mm 3.1 ± 0.13 (0.3 ± 0.1) 3.2 ± 0.18 (0.1 ± 0.2)
IDS, mm 1.8 ± 0.12 (0.2 ± 0.1) 1.9 ± 0.12 (0.1 ± 0.2)
Fractional Shortening, % 43.8 ± 1.7 (-2.3 ± 1.7) 40.6 ± 2.4 (-1.1 ± 1.2)
AWTs, mm 1.2 ± 0.09 (-0.13 ± 0.13) 1.2 ± 0.12 (0.03 ± 0.08)
AWTd, mm 0.8 ± 0.07 (-0.07 ± 0.1) 0.8 ± 0.1 (0.07 ± 0.1)
PWTs, mm 1.6 ± 0.03 (-0.43 ± 0.08) 1.4 ± 0.16 (-0.43 ± 0.29)
PWTd, mm 1.0 ± 0.05 (-0.75 ± 0.12) 1.0 ± 0.13 (-0.42 ± 0.18)
Post-pacing data (and changes from pre-pacing baseline) are presented as group means ± SEM. Comparisons between groups were performed with 
unpaired T-tests. IDD, IDS, intraventricular dimensions at end-diastole, end-systole; AWTs, AWTd, anterior wall thicknesses at end-systole, end-
diastole; PWTs, PWTd, posterior wall thicknesses at end-systole, end-diastole.Page 6 of 12
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Immunofluorescence Images of Cx43 and Cadherin Staining in the Epicardial and Endocardial Regions of Sham-Paced and Paced HeartsFigure 2
Immunofluorescence Images of Cx43 and Cadherin Staining in the Epicardial and Endocardial Regions of 
Sham-Paced and Paced Hearts. Cx43 immunosignal area is higher in the endocardium than the epicardium in sham-paced 
hearts (Panels A and B). In the paced hearts, Cx43 immunosignal area is decreased specifically at the endocardium, thereby 
eliminating the gradient of endocardial to epicardial Cx43 immunosignal area seen in the sham-paced hearts (Panels C and D). 
Cadherin staining pattern and area is unchanged in the paced hearts (Panels E-H). Co-localization of Cx43 and cadherin immu-
nosignal, as demonstrated by the merged images, is statistically unchanged in the paced hearts compared to sham-paced con-
trols (Panels I-L). Quantification of Cx43 immunosignal area shows an increasing epicardial-to-endocardial gradient in the sham 
but not in the paced mice, due to decreased signal area specifically in the epicardial region of the paced mice (Panel M). Aver-
age Cx43 gap junction (GJ) plaque size appears to increase from epicardium to endocardium in sham but not paced mice, 
although these differences were not statistically significant (Panel N). There were no significant differences in the number of 
Cx43 GJ plaques per high power field in epicardial vs. endocardial segments of sham and paced mice (Panel O). Cx43 immuno-
staining pattern appeared similar at the RV apex of sham (Panel P) and paced hearts (Panel Q). RV epicardial surface is denoted 
by asterisks. Epi, epicardial region; Endo, endocardial region.
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BMC Physiology 2008, 8:8 http://www.biomedcentral.com/1472-6793/8/8despite significant reductions in Cx43 immunosignal area
and mRNA abundance in the paced hearts, overall Cx43
protein expression levels are preserved.
Altered Distribution of Cx43 in Paced Hearts
Since total endocardial Cx43 protein levels in the paced
hearts were unchanged despite reduced mRNA levels and
immunosignal area, we considered that pacing might
have resulted in redistribution of Cx43 from the sarco-
lemma into non-sarcolemmal pools. Fractionation of
heart samples demonstrated significantly reduced Cx43
abundance in the sarcolemma-enriched fraction isolated
from paced hearts compared with sham-paced controls
(40.4 ± 8.7% decrease in the paced hearts; p < 0.05; n = 11
sham and 12 paced hearts; Figure 5A). In contrast, Cx43
levels in the supernatant (non-sarcolemmal fraction)
increased by 104.0 ± 35.5% (p < 0.05; Figure 5A). These
findings suggest that the intracellular distribution of car-
diac Cx43 may be altered by short-term pacing with a
reduced proportion that is localized to the sarcolemma.
With reduced Cx43 mRNA levels despite preserved total
protein abundance and an apparent redistribution of
Cx43 immunosignal from the sarcolemma, we predicted
that the process of degradation of gap junction moieties
might be disrupted, resulting in an accumulation of ubiq-
uitinated Cx43 in the paced hearts. We tested this predic-
tion by immunoprecipitating Cx43 in lysates from five
sham-paced and five paced hearts, followed by gel electro-
phoresis and blotting for ubiquitin. We observed a sub-
stantially increased expression of ubiquitinated forms in
the paced hearts (Figure 5B). These findings suggest that
while Cx43 immunosignal area and mRNA levels are
decreased, overall Cx43 protein levels in the paced hearts
are preserved, possibly due to a combination of decreased
production, altered intracellular distribution and dis-
rupted degradation of Cx43.
Electrocardiographic and Electrophysiologic Parameters 
are Unaltered after Short-Term Pacing
We next investigated whether pacing-induced changes in
Cx43 expression were associated with persistent altera-
tions in electrocardiographic and electrophysiologic indi-
ces. After cessation of pacing, we did not detect significant
changes in electrocardiographic parameters in the paced
mice when compared with baseline values or sham-paced
controls (Table 3). There was also no significant difference
between paced and sham-paced mice in refractoriness as
determined by PES after the pacing period (Table 3). Fur-
thermore, PES with single and double extrastimuli did not
result in sustained ventricular arrhythmias in any of the
mice tested. Thus, there was no effect of short-term pacing
at rates just above sinus in wild type mice on electrocardi-
ographic or electrophysiologic parameters. These data
suggest that the observed pacing-induced changes in Cx43
distribution are not sufficient, in the absence of other
insults to the myocardium, to cause a demonstrable
arrhythmogenic effect.
Discussion
In this study, we investigated the effects of short-term, sin-
gle-lead ventricular pacing on Cx43 expression and distri-
Cx43, Cx45, Cx40 and Cadherin Protein Levels are Unchanged in Paced HeartsFigure 4
Cx43, Cx45, Cx40 and Cadherin Protein Levels are 
Unchanged in Paced Hearts. A) Cx43 protein abun-
dance in the paced hearts was unchanged compared to sham-
paced controls. B) Immunoblotting for cadherin, Cx45 and 
Cx40 reveals no significant differences in the mean band den-
sities of these proteins normalized to GAPDH in the paced 
endocardial lysates compared with samples from sham-paced 
hearts.
B.
A.
Cadherin
GAPDH
Sham-Paced Paced
Cx45
Cx40
Cx43
GAPDH
Sham-Paced Paced
Quantitative Real-Time PCR (qRT-PCR) Demonstrates Decreased Cx43 mRNA Levels in Paced H artsFigure 3
Quantitative Real-Time PCR (qRT-PCR) Demon-
strates Decreased Cx43 mRNA Levels in Paced 
Hearts. Both the endocardium and the epicardium of the LV 
free wall demonstrated significantly reduced Cx43 mRNA 
levels after the short-term pacing protocol.
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BMC Physiology 2008, 8:8 http://www.biomedcentral.com/1472-6793/8/8bution. We found that pacing at the epicardial surface of
the RV using the subdiaphragmatic approach was associ-
ated with dyssynchronous systolic contraction of the left
ventricle. Pacing for only six hours at rates within 10% –
15% of sinus rhythm resulted in significantly reduced
membrane-based Cx43 immunosignal in the endocardial
regions of the LV free wall. While levels of Cx43 mRNA
were significantly decreased, Cx43 protein abundance was
unchanged by pacing in lysates isolated from the endocar-
dial third of the LV free wall. Fractionation of ventricular
lysates was consistent with a partial redistribution of Cx43
protein from the sarcolemma into non-sarcolemmal
pools in the paced hearts compared to sham-paced con-
trols. Immunoprecipitation of Cx43 and blotting for
ubiquitin demonstrated a substantially increased accumu-
lation of ubiquitinated Cx43 in the paced hearts. Thus,
our studies suggest that short-term pacing results in signif-
icant reductions in Cx43 transcription and/or mRNA sta-
bility, altered intracellular distribution of gap junction
protein, and a disruption in the process of degradation of
Cx43.
It is intriguing that in the absence of an underlying disease
process, such as tachycardia-induced cardiomyopathy,
hypertrophy or ischemia, short-term pacing of the heart at
rates just above that of normal sinus rhythm should pro-
duce significantly decreased Cx43 mRNA levels and intra-
cellular redistribution of Cx43 protein. Nevertheless, our
observations are in keeping with findings from pacing
studies in other animal models. Patel, et al, performed a
study in which dogs were paced for 21 days at rates 10%
– 15% above the normal sinus rate [11], in contrast to
canine models of pacing-induced heart failure in which
the ventricles are paced at more than twice the normal
sinus rate [30-32]. Patel and colleagues observed an
apparent redistribution of Cx43 labeling from the interca-
lated discs to the lateral cell membranes of myocytes close
to the site of pacing. This redistribution of Cx43 immu-
nosignal is reminiscent of the gap junction remodeling
seen in the peri-infarct zone of experimental myocardial
infarction [6]. However, acute pacing such as that per-
formed in the present study may be insufficient to cause
gap junction remodeling of the extent seen in ischemic
conditions.
In another model of the effects of chronic dyssynchrony,
dogs studied four weeks after radiofrequency ablation of
the left bundle branch were found to have Cx43 laterali-
zation that was associated with reductions in conduction
velocity, action potential duration and refractory period
[10]. Lateralization of Cx43 signal and the accompanying
electrophysiologic alterations in the canine left bundle
branch block model were limited to epicardial regions in
the late-activated lateral wall of the left ventricle. Altered
stress-strain relationships during ventricular pacing have
been observed previously using magnetic resonance imag-
ing [33,34]. Hence, it is conceivable that altered stress-
strain relationships, owing to intraventricular and inter-
ventricular dyssynchrony, may be important factors
underlying altered intracellular gap junction distribution
in the left bundle branch block model, as well as in our
model of epicardial right ventricular pacing.
While altered gap junction expression was observed after
several weeks of pacing or experimentally induced left
bundle branch block in the canine model, other data sug-
gest that changes in gap junction expression may be
induced over a much shorter time frame. Ischemia
induced by cessation of perfusion for up to 40 min in the
isolated rat heart resulted in dephosphorylation and redis-
tribution of Cx43 from the intercalated disc, without a net
loss of Cx43 protein abundance from the myocardium.
Lateralized Cx43 immunosignal in the isolated ischemic
rat heart appears to be mainly phosphorylated in those
hearts that recovered contractile function, but nonphos-
phorylated in those hearts that did not recover function
Alterations in Cx43 Distribution and Ubiquitination with Pac-ingFi ure 5
Alterations in Cx43 Distribution and Ubiquitination 
with Pacing. A) Fractionation of heart samples suggests 
that Cx43 is reduced in the sarcolemma-enriched fraction of 
the paced hearts and increased in the non-sarcolemmal 
supernatant. B) Immunoprecipitation for Cx43 and blotting 
for ubiquitin suggests that there is an increased accumulation 
of ubiquitinated Cx43 in the paced hearts compared to 
sham-paced controls. In this image, mono-ubiquitinated Cx43 
is seen just above the 40 kD size marker and poly-ubiquiti-
nated forms of Cx43 appear as a slower migrating smear.
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BMC Physiology 2008, 8:8 http://www.biomedcentral.com/1472-6793/8/8during reperfusion [12]. Based on these data, we predicted
that short-term pacing in the mouse may also result in
redistribution of Cx43 signal within the ventricular myo-
cyte.
The effect of short-term pacing on connexin expression
has been previously described in the setting of strong elec-
tric currents, which were up to 100 times greater than
those used in this study and represented a model of car-
diac tissue damage [21]. In that study, Sambelashvili et al.
provided fundamental insight into cardiac stimulation by
demonstrating the effect of acute tissue damage on virtual
electrode polarization patterns. In addition, they observed
changes in local connexin expression near the stimulating
electrode under control conditions (10 mA) and "dam-
age" conditions (40 mA). The extent of connexin loss was
greater under damage conditions suggesting a voltage
dose-response. Our study differs in that we used the min-
imum current density (= 0.4 mA) to ensure sustained cap-
ture. Our intention was to model altered activation rather
than acute tissue damage. Interestingly, our exhaustive
studies of tissue near the site of stimulation did not reveal
local changes in connexin expression. However, we did
observe changes that were distant and more diffuse, yet
more subtle.
Our results demonstrating a gradient of increasing epicar-
dium to endocardium Cx43 immunostaining area in the
sham-paced hearts are consistent with data presented by
other groups. Yamada et al. observed a similar transmural
gradient of Cx43 immunosignal distribution in mice of
the same strain as that used for our study [17]. A transmu-
ral gradient of Cx43 expression in the canine heart has
been associated with gradients in conduction velocity and
action potential duration [32]. These data suggest that
regional heterogeneities in the expression of Cx43 may
underlie important electrophysiologic properties of the
heart. In this study, we have observed that short-term pac-
ing at rates just over that of sinus rhythm eliminates the
transmural gradient of Cx43 immunosignal area. While
the normally functioning heart may be able to absorb sub-
tle alterations in the distribution of Cx43, such as those
induced by short-term pacing, in the setting of additional
insults similar changes in Cx43 distribution may result in
more deleterious electrophysiologic consequences.
Previously, we and others have observed significant
changes in ECG parameters and a substantially elevated
risk of lethal ventricular tachyarrhythmias in conditional
models of decreased cardiac Cx43 expression [9,35-37]. In
the present study, we have observed no persistent changes
in the ECG and no increased inducibility of arrhythmias
after cessation of pacing despite significant intracellular
redistribution of Cx43 protein. Clearly, the magnitude of
altered Cx43 localization due to short-term pacing in and
of itself is insufficient to result in significant arrhyth-
mogenicity. In the setting of reduced baseline Cx43
expression, however, such as we and others have
described in the diseased heart [3-6], or in combination
with superimposed electrophysiologic changes due to
ischemia, pacing-induced gap junction remodeling may
have significant arrhythmic implications. Furthermore,
our present findings do not rule out the possibility that
more prolonged pacing might promote additional
changes in Cx43 expression and distribution that would
have potentially pro-arrhythmic effects.
The Cx43 gap junction is known to be degraded along the
ubiquitin proteasome pathway, with involvement of the
endosome/lysosome either sequentially or in parallel
[38,39]. Ubiquitination and subsequent degradation of
Cx43 is a highly regulated process, in which epidermal
growth factor (EGF) may play a prominent role [40,41].
However, while EGF-induced ubiquitination of Cx43 is
associated with hyperphosphorylation of the gap junction
protein, we did not detect a change in the phosphoryla-
tion status of Cx43 in the paced endocardial myocardium.
This suggests that the ubiquitinated forms of Cx43 may
accumulate in the paced hearts in a process independent
of EGF.
We intend to use the pacing model to broaden our under-
standing of the role of Cx43 and its regulation in cardiac
disease. However, an important potential limitation of
this model is that the mechanisms underlying pacing-
induced changes in gap junction expression are not neces-
sarily the same as those responsible for gap junction
remodeling observed in ischemia, the peri-infarct zone or
other pathological states. Nonetheless, defining the mech-
anisms responsible for pacing-induced alterations in the
intracellular distribution of Cx43 will allow us to generate
hypotheses that will be testable in models of cardiac dis-
ease.
Table 3: Electrocardiographic Indices and Electrophysiologic 
Data in C57BL/6J Wildtype Sham and Paced Mice
Sham-Paced, 6 hr Paced, 6 hr
QRS Duration, ms 11.1 ± 0.7 (-1.3 ± 0.7) 14.1 ± 1.0 (0.9 ± 1.1)
RR Interval, ms 144.6 ± 8.0 (12.6 ± 8.3) 144.6 ± 4.7 (0.9 ± 7.0)
QTc, ms 97.7 ± 4.2 (-6.7 ± 5.7) 106.2 ± 2.3 (0.6 ± 4.1)
VERP100, ms 34.3 ± 4.5 34.2 ± 3.0
VERP80, ms 36.3 ± 4.3 35.0 ± 3.6
Post-pacing data (and changes from pre-pacing baseline) are 
presented as group means ± SEM. Comparisons between groups 
were performed with unpaired T-tests. For electrocardiographic 
indices, n = 8 sham and 14 paced; for electrophysiologic data (VERP), 
n = 5 in each group. VERP, ventricular effective refractory period.Page 10 of 12
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BMC Physiology 2008, 8:8 http://www.biomedcentral.com/1472-6793/8/8Conclusion
In summary, we report that short-term cardiac pacing at
rates just fast enough to ensure capture, induces mechan-
ical dyssynchrony of the left ventricle, significantly
decreased Cx43 mRNA levels and partial redistribution of
Cx43 protein in the murine heart. These data suggest that
limited exposure to dyssynchronous activation results in
remodeling of the cardiac gap junctions in the absence of
sustained measurable effects on contractility or arrhyth-
mic inducibility. However, in the setting of cardiac disease
with decreased baseline Cx43 expression, dyssynchronous
activation with its attendant effects on gap junction
remodeling may further exacerbate arrhythmic complica-
tions and worsen cardiac performance.
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